N A T van der Maas Selected Research

DTP-IPV-Hib vaccine

12/2007

[Safety surveillance in the National Vaccination Programme; fewer adverse events with the DTP-IPV-Hib vaccine after the transition to an acellular pertussis component in 2005].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N A T van der Maas Research Topics

Disease

3	Whooping Cough (Pertussis) 01/2020 - 07/2007
2	Infections 03/2009 - 07/2008
2	Tetanus 12/2007 - 07/2007
1	Human Influenza (Influenza) 01/2016
1	Multiple Sclerosis 01/2012
1	Gastroenteritis 07/2008
1	Poliomyelitis (Polio) 12/2007
1	Diphtheria 07/2007

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 01/2016 - 07/2007
1	AntibodiesIBA 01/2020
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2016
1	RIX4414 vaccineIBA 07/2008
1	RotaTeqIBA 07/2008
1	DTP-IPV-Hib vaccineIBA 12/2007
1	Combined VaccinesIBA 12/2007